Small clinical study· 2014

The efficacy of peptide bioregulators of vessels in lower urinary tract symptoms and vasculogenic erectile dysfunction

Kitachev KV|Khavinson VK|Kuznik BI

Advances in Gerontology

PubMed
25051774
Evidence level
weak
Verification
verified

Summary

A small regional clinical study assessed the vascular tripeptide Vezugen in men with vasculogenic erectile dysfunction and urinary symptoms.

Limitations

Small regional study|Limited methodological detail|Unclear blinding and comparator|Independent replication absent

Linked peptides

Important PeptiBrief is an educational information platform. It does not diagnose, prescribe, sell peptides, recommend dosing, encourage self-experimentation or replace qualified medical care. Published scientific evidence is kept separate from community observations and uncertainty.